Novartis breast cancer drug Kisqali wins European panel backing

ZURICH A European Medicines Agency (EMA) panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer.The EMA's Committee for Medicinal Products for Human Use (CHMP) backed Kisqali in comb
Read More

Most Americans say Republican healthcare plan will be harmful: Reuters/Ipsos poll

NEW YORK When U.S. Senate Republicans unveil their plan to overhaul America's healthcare system, they will face a skeptical public that already does not buy the justification for an earlier version that passed the House of Representatives, according to a Reuters/Ipsos poll released on Wednesday.  T
Read More

GSK wins $235 million from Teva in Coreg patent trial

<span class="articleLocation">A U.S. jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg, court documents showed.A federal jury in Wilmington, Delaware on Tuesday found that Te
Read More

Ohio county claims top spot in America’s opioid death spiral

DAYTON, Ohio Scott Weidle is struggling with the death of his son Daniel, who died from a heroin overdose 18 months ago, one day after Christmas.Daniel, who was 30 when he died, was a father of three young boys: Dylan, Landon and Gavin."I got the call laying on the beach," Weidle, 58, said. "Worst d
Read More

Cigna stays in Obamacare for now; Anthem reduces participation

NEW YORK U.S. healthcare insurer Cigna Corp said on Wednesday it will continue to offer individual coverage under Obamacare for now while rival Anthem Inc announced it was shrinking its participation, amid uncertainty over the fate of the government-subsidized program.Wednesday was the deadline for
Read More

FDA moves to prevent Pharma from ‘gaming’ generic drug system

WASHINGTON The U.S. Food and Drug Administration moved on Wednesday to prevent pharmaceutical companies from "gaming" the system to block or delay entry of generic rivals.FDA Commissioner Scott Gottlieb said in a blog post that the agency plans to hold a public meeting on July 18 to identify ways ph
Read More

Drugmaker Mylan gets boost from unlikely source: coal

NEW YORK Mylan N.V. is best known for producing EpiPen emergency allergy treatments and generic drugs.But a non-pharmaceutical offering – refined coal – has quietly generated hundreds of millions of dollars of tax credits for the company over the last six years that have boosted its bott
Read More

WHO says child from Raqqa among 15 new polio cases in Syria

GENEVA Fifteen new cases of polio have been confirmed in Syria, including a child who may have caught the disease in Raqqa, the World Health Organization said on Tuesday.Aid workers are unable to vaccinate the population in and around Raqqa, a city held by Islamic State militants and a target of U.S
Read More

Novartis eye drug works with fewer injections than rival

ZURICH A Novartis drug to treat a leading cause of vision loss in people over 65 does not need to be injected as frequently as a rival medicine from Regeneron Pharmaceuticals to be effective, clinical trials showed on Tuesday.Novartis said the trials showed its RTH258 drug would reduce the injection
Read More

Worldwide drug sale forecasts fall as pricing pressures mount

LONDON Forecasts for global sales of pharmaceuticals have declined for the first time in a decade as continuing pressure on prices in the key U.S. market has caused analysts to moderate revenue expectations, according to a report on Tuesday.Evaluate Pharma, which compiles consensus numbers based on
Read More
Page 4 of 13« First...23456...10...Last »